CDIP1

CDIP1 is a p53-target pro-apoptotic protein that couples genotoxic and ER stress to programmed cell death through both extrinsic and intrinsic apoptotic routes (PMID:17599062, PMID:24139803). As a transcriptional target of p53, CDIP1 drives caspase-8 cleavage and p53-dependent TNF-α upregulation, establishing a p53→CDIP1→TNF-α axis that sensitizes cells to TNF-α-induced apoptosis (PMID:17599062, PMID:22549949). Upon ER stress, CDIP1 physically associates with BAP31 at the ER membrane, an interaction required for BAP31 cleavage, BAP31-Bcl-2 association, caspase-8/tBid activation, and BAX oligomerization, thereby relaying ER-stress signals to mitochondrial apoptosis; genetic ablation of CDIP1 in mice impairs ER-stress-mediated death (PMID:24139803). CDIP1 further engages the Ca2+-binding protein ALG-2 (PDCD6) in a Ca2+-dependent manner, which adapts it to TSG101/VPS37B/VPS37C-containing ESCRT-I complexes, and binds VAPA/VAPB through a C-terminal FFAT-like motif whose mutation reduces CDIP1-induced caspase-3/7-mediated death (PMID:33503978). CDIP1 localizes to endosomes and is degraded through the lysosomal pathway, with CDK5-dependent phosphorylation at Ser-32 modulating its pro-apoptotic activity, and it induces a cytoprotective autophagic response prior to apoptosis (PMID:38928226). Independently of its apoptotic role, CDIP1 functions as an alternative host cell-surface receptor for the Bacillus cereus pore-forming toxin hemolysin BL (HBL) in LITAF-deficient cells (PMID:32544461).

1. 2007 High

   Established CDIP1 as a p53 effector that engages the extrinsic apoptotic pathway, answering how p53 links genotoxic stress to caspase-8-dependent death.

   Evidence siRNA knockdown of CDIP1 and caspase-8, overexpression, TNF-α neutralization under genotoxic stress

   PMID:17599062

   Open questions at the time

   • Did not define the molecular partners that physically transduce CDIP1 to caspase-8
   • Did not resolve subcellular site of action
2. 2012 Medium

   Showed endogenous CDIP1 level sets the apoptosis-versus-survival decision in response to TNF-α, framing it as a tunable apoptotic rheostat in cancer cells.

   Evidence CDIP1 knockdown/overexpression with TNF-α treatment in vitro and in vivo

   PMID:22549949

   Open questions at the time

   • Single lab
   • Mechanistic link to JNK activation not fully dissected
3. 2013 High

   Identified the ER-membrane BAP31 interaction as the mechanism by which CDIP1 couples ER stress to mitochondrial apoptosis, defining its intrinsic-pathway role.

   Evidence Reciprocal Co-IP, CDIP1 knockout mice, BAX oligomerization and caspase-8/tBid activation assays under ER stress

   PMID:24139803

   Open questions at the time

   • Structural basis of the CDIP1-BAP31 interaction unresolved
   • How ER stress triggers complex assembly not defined
4. 2020 High

   Revealed a non-apoptotic function of CDIP1 as an alternative receptor for the B. cereus HBL toxin, distinct from its p53/apoptosis biology.

   Evidence Two sequential genome-wide CRISPR-Cas9 knockout screens, validation in LITAF-deficient KO cells and mice with lethal HBL challenge

   PMID:32544461

   Open questions at the time

   • Binding interface between CDIP1 and HBL not mapped
   • Relationship between receptor role and apoptotic function unknown
5. 2021 Medium

   Mapped CDIP1 into Ca2+-responsive membrane-trafficking machinery, identifying ALG-2, ESCRT-I, and VAPA/VAPB as partners and an FFAT-like motif as a determinant of its killing activity.

   Evidence Co-IP of GFP-CDIP1, FFAT-like motif mutagenesis, caspase-3/7 assays in HEK293 cells

   PMID:33503978

   Open questions at the time

   • Single lab; reciprocal validation limited
   • How ESCRT-I/VAP engagement mechanistically drives caspase-3/7 activation unclear
6. 2021 Medium

   Demonstrated Cdip1 is a silencing target of exosomal miR-21-5p, defining a route by which CDIP1 suppression confers cytoprotection in ischemic endothelium.

   Evidence Small RNA sequencing, in vitro ischemia/hypoxia model, rat MI model validation

   PMID:33391474

   Open questions at the time

   • Predominantly phenotypic; downstream CDIP1 pathway not dissected in this context
7. 2023 Medium

   Placed CDIP1 downstream of an ELK1/miR-31-5p axis, showing its 3'UTR silencing suppresses apoptosis while promoting CRC migration, invasion, and autophagy.

   Evidence Dual-luciferase 3'UTR reporter, CDIP1 siRNA, miR-31-5p and ELK1 manipulation, xenograft

   PMID:37547727

   Open questions at the time

   • Single lab
   • Direct molecular effectors of CDIP1 in CRC not identified
8. 2024 Medium

   Defined post-translational and trafficking control of CDIP1, showing endosomal localization, lysosomal degradation, CDK5/Ser-32 phosphoregulation, and autophagy as a cytoprotective brake on its apoptotic activity.

   Evidence Subcellular fractionation, Ser-32 phosphomimetic mutagenesis, CDK5 and VPS34 inhibitors, caspase assays in MCF-7 cells

   PMID:38928226

   Open questions at the time

   • Direct kinase-substrate relationship of CDK5 on Ser-32 not biochemically reconstituted
   • Mechanism coupling endosomal/lysosomal handling to apoptotic output unclear
9. 2025 Medium

   Extended CDIP1 3'UTR regulation to cardiac disease, showing miR-133b-3p silencing of CDIP1 suppresses Ang II-induced cardiomyocyte hypertrophy and apoptosis.

   Evidence Dual-luciferase 3'UTR reporter, miR-133b-3p overexpression, CDIP1 siRNA, Ang II hypertrophy model

   PMID:39943804

   Open questions at the time

   • Single lab
   • CDIP1 effector pathway in cardiomyocytes not dissected

• How CDIP1's apoptotic signaling, membrane-trafficking interactions, and toxin-receptor function are mechanistically integrated, and what its structural organization is, remains unresolved.
• No structural model of CDIP1 or its complexes
• Relationship between receptor and apoptotic roles unknown
• Direct catalytic or enzymatic activity, if any, undefined